Marina Urena

Marina Urena

Interventional cardiologist / Cardiologist
HU PARIS NORD SITE BICHAT APHP - Paris, France

Latest contributions

Which valve is best for my patient?

21 May 2025 – From EuroPCR 2025

This session guides clinicians in selecting the most appropriate transcatheter aortic valve tailored to individual patient characteristics. Through diverse case discussions, including patients with coronary artery disease, small anatomies, bicuspid valves, and surgical bioprostheses, it elucidates decision-making processes and planning for complex TAVI anatomies.

Which valve is best for my patient?

Pioneering innovation in the treatment of mitral and tricuspid regurgitation

20 May 2025 – From EuroPCR 2025

This interventional session explores therapeutic strategies for mitral and tricuspid regurgitation, focusing on the clinical decision-making process between repair and replacement. Through two clinical cases, a 78-year-old male patient with severe degenerative mitral regurgitation and an 88-year-old female patient with atrial functional mitral regurgitation, experts review available...

Pioneering innovation in the treatment of mitral and tricuspid regurgitation

TMVR in challenging scenarios

20 May 2025 – From EuroPCR 2025

Navigate the challenges of transcatheter mitral valve replacement (TMVR) in complex clinical scenarios. This session explores treatment options when clipping is not feasible in a patient with heart failure and severe MR, management of multivalvular disease, advanced septal crossing techniques, and strategies for non-surgical candidates ineligible...

TMVR in challenging scenarios

Rapid-Fire - Tricuspid TEER

25 Nov 2024 – From PCR London Valves 2024

Discover a rapid-fire session showcasing selected PCR London Valves 2024 clinical cases focused on Tricuspid Transcatheter Edge-to-Edge Repair (T-TEER). Explore a range of complications and innovative solutions, such as cardiogenic shock, single leaflet device attachment, and increased transvalvular gradients. Gain valuable insights into the challenges and...

Rapid-Fire - Tricuspid TEER

Recurrent and residual mitral regurgitation after transcatheter repair - Assessment and management

25 Nov 2024 – From PCR London Valves 2024

Struggling with recurrent or residual mitral regurgitation after transcatheter repair? This video answers your questions with actionable strategies to assess, prevent and treat this challenging condition.

Learn how to pinpoint the mechanisms and severity of mitral regurgitation using advanced imaging, hear what interventionalists need to know to...

Recurrent and residual MR after transcatheter repair - Assessment and management

Featured research - Mitral valve (Part 2)

24 Nov 2024 – From PCR London Valves 2024

Dive deeper into the latest mitral valve research in this second part of the featured research session. Uncover insights from cutting-edge studies on the TEND-RING Tendyne mitral valve-in-ring registry, the feasibility and results of mitral valve clipping after failed surgical repair, outcomes of TEER for primary...

Featured research - Mitral valve (Part 2)

Percutaneous tricuspid treatment in challenging anatomies

16 May 2024 – From EuroPCR 2024

Watch this session on percutaneous tricuspid treatment to explore key cases, including managing tricuspid valve-in-valve implantation in a patient with a giant right atrium, transcatheter edge-to-edge repair post-Mustard procedure, and tricuspid replacement in a challenging extreme anatomy case. You'll also learn about cross-caval treatment for torrential...

Percutaneous tricuspid treatment in challenging anatomies

TAVI: new devices, original solutions for procedural complications

15 May 2024 – From EuroPCR 2024

TAVI: new devices, original solutions for procedural complications

Embolic protection, TAVI, heart failure and artificial intelligence: what's new in 2023

19 May 2023 – From EuroPCR 2023

This session covers various topics related to transcatheter aortic valve replacement, including the Protect Head-to-Head study on full-body embolic protection during TAVR, the FLOWer device for complete embolic protection, the use of a pulsing aspiration pump for percutaneous thrombectomy, and many more innovation updates from 2023.

Embolic protection, TAVI, heart failure and artificial intelligence: what is new in 2023

Complications and complexity of LAA closure

18 May 2023 – From EuroPCR 2023

Explore the complications and complexities of LAA closure procedures in this session: witness the skilled double closure of a leaked LAAC following Occlutech device dislocation, discover the retrieval of a LAA occluder embolized to the mitral valve, uncover the rare occurrence of subacute pulmonary artery perforation...

Complications and complexity of LAA closure

All you need to know before starting a mitral valve-in-valve or valve-in-ring procedure

29 Nov 2022 – From PCR London Valves 2022

Discover all you need to know before starting a mitral valve-in-valve or valve-in-ring procedure in this session: learn how to evaluate patients with an indication for these procedures, how to identify the risks  and determine the choice of prosthesis, the different steps of the procedure using a transseptal approach, and...

All you need to know before starting a mitral valve-in-valve or valve-in-ring procedure

Patient-prosthesis mismatch: surgical and transcatheter approaches - LIVE case

28 Nov 2022 – From PCR London Valves 2022

Consult this session to discover different surgical and transcatheter approaches:

  • Part 1: Bioprosthesis aortic valve stenosis
    A 73-year-old male, with diabetes, BMI 29, atrial fibrillation, history of SAVR 15 years ago (Perimount 27) presents a symptomatic severe surgical valve stenosis with a preserved LV function.
    During the live time...
Patient-prosthesis mismatch: surgical and transcatheter approaches

Predicting and managing TAVI conduction related disorders

20 May 2022 – From EuroPCR 2022

Get key learnings on conduction disorders after TAVI, the role of temporary pacing devices and different strategies to reduce permanent pacemaker implants to the minimum.

Predicting and managing TAVI conduction related disorders

EuroPCR 2022 Hotlines / Late-Breaking Trials in mitral and tricuspid: MITRA-TUNE, MitraBridge, TriCLASP, CLASP TR, and more!

19 May 2022 – From EuroPCR 2022

Find out more about various studies & registries in mitral and tricuspid! MitraClip in atrial functional mitral regurgitation, two-year outcomes of MitraClip as a bridge to heart transplantation, TriCLASP post-market study, CLASP TR study one-year results, Cardioband TR early feasibility study, and initial 30-day results from...

EuroPCR 2022 Hotlines / Late-Breaking Trials in mitral and tricuspid: MITRA-TUNE, MitraBridge, TriCLASP, CLASP TR, and more!

How should I treat? - How to reduce cardiac conduction disturbance with Sapien 3 valve?

16 Mar 2022

Conduction disturbances remain the most common complications of TAVI and its main drawback compared to surgery. How would you treat this 82-year-old man, height 1.68 m, weight 112 kg, with peripheral artery disease, who presented with severe aortic stenosis and symptoms of NYHA Class 3 breathlessness?

Oualid Zouaghi

Author

Oualid Zouaghi

TAVI and the conduction system

27 Jun 2020 – From PCR e-Course 2020

Watch this case discussion if you want to appreciate the factors that predict conduction abnormalities during TAVI (and how to avoid them), to understand which patients are at risk of late abnormalities and need prolonged monitoring after TAVI and to identify which patients require permanent pacemaker...

TAVI and the conduction system

Transcatheter mitral valve interventions in failed mitral repair, replacement and mitral stenosis

21 May 2019 – From EuroPCR 2019

Consult this session to learn how to select and screen patients for transcatheter mitral valve interventions, when & how to perform this kind of procedure, and how to avoid and manage related complications.

Transcatheter mitral valve interventions in failed mitral repair, replacement and mitral stenosis

TAVI in patients with longer life expectancy: challenges and opportunities

21 May 2019 – From EuroPCR 2019

Consult this session to understand the treatment options for TAVI failures and to explore the challenges and opportunities of TAVI in patients with longer life expectancy, which remains a risky procedure, and also to understand the importance of a routine follow-up of the bioprosthetic valves to ensure...